Corneal Pachymetry Market Expected to Reach $435.44 Million by 2032, Growing at a CAGR of 4.5%

Market Overview:

The global corneal pachymetry market size is expected to reach USD 435.44 million by 2032, exhibiting the CAGR of 4.5% during the forecast period.

What is Corneal Pachymetry?

Corneal thickness, as calculated by pachymetry, is crucial in the eye care field for many reasons. Pachymetry can notify healthcare donors if the cornea is expanded. Medical conditions such as Fuch’s Dystrophy can escalate fluid in the cornea and lead to an escalation in comprehensive breadth. Even adorning contact lenses can often create significant corneal swelling. This might be arduous to observe beneath the microscope. But pachymetry will portray a precise swelling in thickness.

Download Free Sample PDF Copy of the Report:

https://www.polarismarketresearch.com/industry-analysis/corneal-pachymetry-market/request-for-sample

Major Participants:

Some of the major players in the market include:

• AMETEK Inc. (US)
• Carl Zeiss AG (India)
• CSO S.r. (India)
• DGH Technology Inc. (US)
• Escalon Medical Corp. (US)
• EssilorLuxottica (France)
• Halma Plc (UK)
• Konan Medical Inc. (Japan)
• MEDA Co. Ltd. (China)
• MicroMedical Devices Inc. (US)
• NIDEK Co. Ltd. (Japan)

Growth Prospects and Trends

Growing consciousness about many health issues, with escalated details about indicators and health conditions, with the improved approach to the internet. The increasing initiatives to encourage premature observation of eye-connected health intricacies by healthcare donors are easing the corneal pachymetry demand in the long run.

Moreover, technological progressions in corneal pachymetry devices have also brought about market growth. Makers are consistently pioneering to advance more precise, adaptable, and mobile devices improving the efficacy and dependability of corneal thickness quantification. The amalgamation of progressive imaging technologies such as OCT and Scheimpflug imaging has sanctioned clinicians to acquire complete corneal thickness maps with escalated accuracy and resolve, easing superlative diagnosis and treatment planning.

Regional Insights

• North America makes up the majority of the market. This is primarily because of the escalated scope of glaucoma and refractive surgeries. The obtainability of a loftier healthcare medication framework in the region is maximally pushing global corneal pachymetry market growth.

• Throughout the projection period, it is expected that the Asia Pacific market will grow at a faster CAGR. This results from the escalating existence of an elevated aggregate of glaucoma cases, mainly in India. The global manifestation of glaucoma in 2020 inscribed approximately 76 million, while India gauges for a 20% share at the worldwide level.

Corneal Pachymetry Market, Regional Outlook (Revenue – USD Million, 2019-2032)

• North America
  • Product Outlook
    • Non-Handheld
    • Handheld
  • Type Outlook
    • Ultrasonic Method
    • Optical Method
  • End-user Outlook
    • Specialty clinics
    • Hospitals
    • Others
• Europe
  • Product Outlook
    • Non-Handheld
    • Handheld
  • Type Outlook
    • Ultrasonic Method
    • Optical Method
  • End-user Outlook
    • Specialty clinics
    • Hospitals
    • Others
• Asia Pacific
  • Product Outlook
    • Non-Handheld
    • Handheld
  • Type Outlook
    • Ultrasonic Method
    • Optical Method
  • End-user Outlook
    • Specialty clinics
    • Hospitals
    • Others

Recent Developments:

• March 2023 – Occuity:
  Occuity unveiled its PM1 Pachymeter, a non-contact handheld device designed to measure corneal thickness. This medical test offers a painless and efficient way to assess eye health. In addition, Occuity also introduced the AX1 Axiometer prototype, a device focused on myopia control, helping manage and monitor myopia progression.

The corneal pachymetry market, which pertains to the measurement of corneal thickness, has been steadily growing, driven by various factors within the ophthalmic industry. One of the primary drivers of this market is the increasing prevalence of ocular disorders such as glaucoma, keratoconus, and corneal edema, where accurate measurement of corneal thickness is crucial for diagnosis and treatment planning.